0001663674-18-000003.txt : 20180531 0001663674-18-000003.hdr.sgml : 20180531 20180531083329 ACCESSION NUMBER: 0001663674-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180531 DATE AS OF CHANGE: 20180531 EFFECTIVENESS DATE: 20180531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BluDiagnostics, Inc. CENTRAL INDEX KEY: 0001663674 IRS NUMBER: 475254882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313574 FILM NUMBER: 18870094 BUSINESS ADDRESS: STREET 1: 123 N. BLOUNT STREET STREET 2: SUITE 307 CITY: MADISON STATE: WI ZIP: 53703 BUSINESS PHONE: 608-338-4289 MAIL ADDRESS: STREET 1: 123 N. BLOUNT STREET STREET 2: SUITE 307 CITY: MADISON STATE: WI ZIP: 53703 D 1 primary_doc.xml X0708 D LIVE 0001663674 BluDiagnostics, Inc. 123 N. BLOUNT STREET SUITE 307 MADISON WI WISCONSIN 53703 608-338-4289 DELAWARE Genocons LLC None Corporation true 2015 Jodi L. Schroll 123 N. Blount St. Ste. 307 Madison WI WISCONSIN 53703 Executive Officer Director Sarah Katherine Brenner 123 N. Blount St. Ste. 307 Madison WI WISCONSIN 53703 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-05-15 false true false 0 3400000 3400000 0 false 2 0 0 0 true The Issuer shall use the proceeds from the offering as working capital for product development and other general corporate purposes. The executive officers may receive compensation from the Issuer's investment proceeds. false BluDiagnostics, Inc. Sarah Katherine Brenner Sarah Katherine Brenner Chief Executive Officer 2018-05-30